Search

Your search keyword '"Blando, Jorge"' showing total 368 results
Start Over Author "Blando, Jorge"
368 results on '"Blando, Jorge"'

1. B cells and tertiary lymphoid structures promote immunotherapy response

Author

Helmink, Beth A, Reddy, Sangeetha M, Gao, Jianjun, Zhang, Shaojun, Basar, Rafet, Thakur, Rohit, Yizhak, Keren, Sade-Feldman, Moshe, Blando, Jorge, Han, Guangchun, Gopalakrishnan, Vancheswaran, Xi, Yuanxin, Zhao, Hao, Amaria, Rodabe N, Tawbi, Hussein A, Cogdill, Alex P, Liu, Wenbin, LeBleu, Valerie S, Kugeratski, Fernanda G, Patel, Sapna, Davies, Michael A, Hwu, Patrick, Lee, Jeffrey E, Gershenwald, Jeffrey E, Lucci, Anthony, Arora, Reetakshi, Woodman, Scott, Keung, Emily Z, Gaudreau, Pierre-Olivier, Reuben, Alexandre, Spencer, Christine N, Burton, Elizabeth M, Haydu, Lauren E, Lazar, Alexander J, Zapassodi, Roberta, Hudgens, Courtney W, Ledesma, Deborah A, Ong, SuFey, Bailey, Michael, Warren, Sarah, Rao, Disha, Krijgsman, Oscar, Rozeman, Elisa A, Peeper, Daniel, Blank, Christian U, Schumacher, Ton N, Butterfield, Lisa H, Zelazowska, Monika A, McBride, Kevin M, Kalluri, Raghu, Allison, James, Petitprez, Florent, Fridman, Wolf Herman, Sautès-Fridman, Catherine, Hacohen, Nir, Rezvani, Katayoun, Sharma, Padmanee, Tetzlaff, Michael T, Wang, Linghua, and Wargo, Jennifer A

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Immunology, Immunization, Cancer, Vaccine Related, Genetics, B-Lymphocytes, Biomarkers, Tumor, Carcinoma, Renal Cell, Cell Cycle Checkpoints, Clone Cells, Dendritic Cells, Follicular, Gene Expression Regulation, Neoplastic, Humans, Immunologic Memory, Immunotherapy, Mass Spectrometry, Melanoma, Neoplasm Metastasis, Phenotype, Prognosis, RNA-Seq, Receptors, Immunologic, Single-Cell Analysis, T-Lymphocytes, Tertiary Lymphoid Structures, Transcriptome, General Science & Technology
Abstract

Treatment with immune checkpoint blockade (ICB) has revolutionized cancer therapy. Until now, predictive biomarkers1-10 and strategies to augment clinical response have largely focused on the T cell compartment. However, other immune subsets may also contribute to anti-tumour immunity11-15, although these have been less well-studied in ICB treatment16. A previously conducted neoadjuvant ICB trial in patients with melanoma showed via targeted expression profiling17 that B cell signatures were enriched in the tumours of patients who respond to treatment versus non-responding patients. To build on this, here we performed bulk RNA sequencing and found that B cell markers were the most differentially expressed genes in the tumours of responders versus non-responders. Our findings were corroborated using a computational method (MCP-counter18) to estimate the immune and stromal composition in this and two other ICB-treated cohorts (patients with melanoma and renal cell carcinoma). Histological evaluation highlighted the localization of B cells within tertiary lymphoid structures. We assessed the potential functional contributions of B cells via bulk and single-cell RNA sequencing, which demonstrate clonal expansion and unique functional states of B cells in responders. Mass cytometry showed that switched memory B cells were enriched in the tumours of responders. Together, these data provide insights into the potential role of B cells and tertiary lymphoid structures in the response to ICB treatment, with implications for the development of biomarkers and therapeutic targets.

Published
2020

4. Supplementary Appendix from Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

Author

Cascone, Tina, primary, Kar, Gozde, primary, Spicer, Jonathan D., primary, García-Campelo, Rosario, primary, Weder, Walter, primary, Daniel, Davey B., primary, Spigel, David R., primary, Hussein, Maen, primary, Mazieres, Julien, primary, Oliveira, Julio, primary, Yau, Edwin H., primary, Spira, Alexander I., primary, Anagnostou, Valsamo, primary, Mager, Raymond, primary, Hamid, Oday, primary, Cheng, Lin-Yang, primary, Zheng, Ying, primary, Blando, Jorge, primary, Tan, Tze Heng, primary, Surace, Michael, primary, Rodriguez-Canales, Jaime, primary, Gopalakrishnan, Vancheswaran, primary, Sellman, Bret R., primary, Grenga, Italia, primary, Soo-Hoo, Yee, primary, Kumar, Rakesh, primary, McGrath, Lara, primary, and Forde, Patrick M., primary

Published
2023
Full Text
View/download PDF

5. Data from Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

Author

Cascone, Tina, primary, Kar, Gozde, primary, Spicer, Jonathan D., primary, García-Campelo, Rosario, primary, Weder, Walter, primary, Daniel, Davey B., primary, Spigel, David R., primary, Hussein, Maen, primary, Mazieres, Julien, primary, Oliveira, Julio, primary, Yau, Edwin H., primary, Spira, Alexander I., primary, Anagnostou, Valsamo, primary, Mager, Raymond, primary, Hamid, Oday, primary, Cheng, Lin-Yang, primary, Zheng, Ying, primary, Blando, Jorge, primary, Tan, Tze Heng, primary, Surace, Michael, primary, Rodriguez-Canales, Jaime, primary, Gopalakrishnan, Vancheswaran, primary, Sellman, Bret R., primary, Grenga, Italia, primary, Soo-Hoo, Yee, primary, Kumar, Rakesh, primary, McGrath, Lara, primary, and Forde, Patrick M., primary

Published
2023
Full Text
View/download PDF

6. Supplementary Data - Supplementary Table 7 from Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

Author

Cascone, Tina, primary, Kar, Gozde, primary, Spicer, Jonathan D., primary, García-Campelo, Rosario, primary, Weder, Walter, primary, Daniel, Davey B., primary, Spigel, David R., primary, Hussein, Maen, primary, Mazieres, Julien, primary, Oliveira, Julio, primary, Yau, Edwin H., primary, Spira, Alexander I., primary, Anagnostou, Valsamo, primary, Mager, Raymond, primary, Hamid, Oday, primary, Cheng, Lin-Yang, primary, Zheng, Ying, primary, Blando, Jorge, primary, Tan, Tze Heng, primary, Surace, Michael, primary, Rodriguez-Canales, Jaime, primary, Gopalakrishnan, Vancheswaran, primary, Sellman, Bret R., primary, Grenga, Italia, primary, Soo-Hoo, Yee, primary, Kumar, Rakesh, primary, McGrath, Lara, primary, and Forde, Patrick M., primary

Published
2023
Full Text
View/download PDF

7. Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma

Author

Gao, Jianjun, Navai, Neema, Alhalabi, Omar, Siefker-Radtke, Arlene, Campbell, Matthew T., Tidwell, Rebecca Slack, Guo, Charles C., Kamat, Ashish M., Matin, Surena F., Araujo, John C., Shah, Amishi Y., Msaouel, Pavlos, Corn, Paul, Wang, Jianbo, Papadopoulos, John N., Yadav, Shalini S., Blando, Jorge M., Duan, Fei, Basu, Sreyashi, Liu, Wenbin, Shen, Yu, Zhang, Yuwei, Macaluso, Marc Daniel, Wang, Ying, Chen, Jianfeng, Zhang, Jianhua, Futreal, Andrew, Dinney, Colin, Allison, James P., Goswami, Sangeeta, and Sharma, Padmanee

Published
2020
Full Text
View/download PDF

8. Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer

Author

Blando, Jorge, Sharma, Anu, Higa, Maria Gisela, Zhao, Hao, Vence, Luis, Yadav, Shalini S., Kim, Jiseong, Sepulveda, Alejandro M., Sharp, Michael, Maitra, Anirban, Wargo, Jennifer, Tetzlaff, Michael, Broaddus, Russell, Katz, Matthew H. G., Varadhachary, Gauri R., Overman, Michael, Wang, Huamin, Yee, Cassian, Bernatchez, Chantale, Iacobuzio-Donahue, Christine, Basu, Sreyashi, Allison, James P., and Sharma, Padmanee

Published
2019

10. Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial

Author

Cascone, Tina, primary, Kar, Gozde, additional, Spicer, Jonathan D., additional, García-Campelo, Rosario, additional, Weder, Walter, additional, Daniel, Davey B., additional, Spigel, David R., additional, Hussein, Maen, additional, Mazieres, Julien, additional, Oliveira, Julio, additional, Yau, Edwin H., additional, Spira, Alexander I., additional, Anagnostou, Valsamo, additional, Mager, Raymond, additional, Hamid, Oday, additional, Cheng, Lin-Yang, additional, Zheng, Ying, additional, Blando, Jorge, additional, Tan, Tze Heng, additional, Surace, Michael, additional, Rodriguez-Canales, Jaime, additional, Gopalakrishnan, Vancheswaran, additional, Sellman, Bret R., additional, Grenga, Italia, additional, Soo-Hoo, Yee, additional, Kumar, Rakesh, additional, McGrath, Lara, additional, and Forde, Patrick M., additional

Published
2023
Full Text
View/download PDF

11. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

Author

Wang, Yinghong, Wiesnoski, Diana H., Helmink, Beth A., Gopalakrishnan, Vancheswaran, Choi, Kati, DuPont, Hebert L., Jiang, Zhi-Dong, Abu-Sbeih, Hamzah, Sanchez, Christopher A., Chang, Chia-Chi, Parra, Edwin R., Francisco-Cruz, Alejandro, Raju, Gottumukkala S., Stroehlein, John R., Campbell, Matthew T., Gao, Jianjun, Subudhi, Sumit K., Maru, Dipen M., Blando, Jorge M., Lazar, Alexander J., Allison, James P., Sharma, Padmanee, Tetzlaff, Michael T., Wargo, Jennifer A., and Jenq, Robert R.

Published
2018
Full Text
View/download PDF

12. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

Author

Amaria, Rodabe N., Reddy, Sangeetha M., Tawbi, Hussein A., Davies, Michael A., Ross, Merrick I., Glitza, Isabella C., Cormier, Janice N., Lewis, Carol, Hwu, Wen-Jen, Hanna, Ehab, Diab, Adi, Wong, Michael K., Royal, Richard, Gross, Neil, Weber, Randal, Lai, Stephen Y., Ehlers, Richard, Blando, Jorge, Milton, Denái R., Woodman, Scott, Kageyama, Robin, Wells, Daniel K., Hwu, Patrick, Patel, Sapna P., Lucci, Anthony, Hessel, Amy, Lee, Jeffrey E., Gershenwald, Jeffrey, Simpson, Lauren, Burton, Elizabeth M., Posada, Liberty, Haydu, Lauren, Wang, Linghua, Zhang, Shaojun, Lazar, Alexander J., Hudgens, Courtney W., Gopalakrishnan, Vancheswaran, Reuben, Alexandre, Andrews, Miles C., Spencer, Christine N., Prieto, Victor, Sharma, Padmanee, Allison, James, Tetzlaff, Michael T., and Wargo, Jennifer A.

Published
2018
Full Text
View/download PDF

13. Supplementary Data from Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner

Author

Shi, Lewis Zhichang, primary, Goswami, Sangeeta, primary, Fu, Tihui, primary, Guan, Baoxiang, primary, Chen, Jianfeng, primary, Xiong, Liangwen, primary, Zhang, Jan, primary, Ng Tang, Derek, primary, Zhang, Xuejun, primary, Vence, Luis, primary, Blando, Jorge, primary, Allison, James P., primary, Collazo, Renata, primary, Gao, Jianjun, primary, and Sharma, Padmanee, primary

Published
2023
Full Text
View/download PDF

14. Data from Blockade of CTLA-4 and PD-1 Enhances Adoptive T-cell Therapy Efficacy in an ICOS-Mediated Manner

Author

Shi, Lewis Zhichang, primary, Goswami, Sangeeta, primary, Fu, Tihui, primary, Guan, Baoxiang, primary, Chen, Jianfeng, primary, Xiong, Liangwen, primary, Zhang, Jan, primary, Ng Tang, Derek, primary, Zhang, Xuejun, primary, Vence, Luis, primary, Blando, Jorge, primary, Allison, James P., primary, Collazo, Renata, primary, Gao, Jianjun, primary, and Sharma, Padmanee, primary

Published
2023
Full Text
View/download PDF

16. Supplementary Data from Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

Author

Daver, Naval, primary, Garcia-Manero, Guillermo, primary, Basu, Sreyashi, primary, Boddu, Prajwal C., primary, Alfayez, Mansour, primary, Cortes, Jorge E., primary, Konopleva, Marina, primary, Ravandi-Kashani, Farhad, primary, Jabbour, Elias, primary, Kadia, Tapan, primary, Nogueras-Gonzalez, Graciela M., primary, Ning, Jing, primary, Pemmaraju, Naveen, primary, DiNardo, Courtney D., primary, Andreeff, Michael, primary, Pierce, Sherry A., primary, Gordon, Tauna, primary, Kornblau, Steven M., primary, Flores, Wilmer, primary, Alhamal, Zainab, primary, Bueso-Ramos, Carlos, primary, Jorgensen, Jeffrey L., primary, Patel, Keyur P., primary, Blando, Jorge, primary, Allison, James P., primary, Sharma, Padmanee, primary, and Kantarjian, Hagop, primary

Published
2023
Full Text
View/download PDF

20. Supplementary Figure Legends from Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

Author

Chen, Pei-Ling, primary, Roh, Whijae, primary, Reuben, Alexandre, primary, Cooper, Zachary A., primary, Spencer, Christine N., primary, Prieto, Peter A., primary, Miller, John P., primary, Bassett, Roland L., primary, Gopalakrishnan, Vancheswaran, primary, Wani, Khalida, primary, De Macedo, Mariana Petaccia, primary, Austin-Breneman, Jacob L., primary, Jiang, Hong, primary, Chang, Qing, primary, Reddy, Sangeetha M., primary, Chen, Wei-Shen, primary, Tetzlaff, Michael T., primary, Broaddus, Russell J., primary, Davies, Michael A., primary, Gershenwald, Jeffrey E., primary, Haydu, Lauren, primary, Lazar, Alexander J., primary, Patel, Sapna P., primary, Hwu, Patrick, primary, Hwu, Wen-Jen, primary, Diab, Adi, primary, Glitza, Isabella C., primary, Woodman, Scott E., primary, Vence, Luis M., primary, Wistuba, Ignacio I., primary, Amaria, Rodabe N., primary, Kwong, Lawrence N., primary, Prieto, Victor, primary, Davis, R. Eric, primary, Ma, Wencai, primary, Overwijk, Willem W., primary, Sharpe, Arlene H., primary, Hu, Jianhua, primary, Futreal, P. Andrew, primary, Blando, Jorge, primary, Sharma, Padmanee, primary, Allison, James P., primary, Chin, Lynda, primary, and Wargo, Jennifer A., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Tables 1 - 11 from Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

Author

Chen, Pei-Ling, primary, Roh, Whijae, primary, Reuben, Alexandre, primary, Cooper, Zachary A., primary, Spencer, Christine N., primary, Prieto, Peter A., primary, Miller, John P., primary, Bassett, Roland L., primary, Gopalakrishnan, Vancheswaran, primary, Wani, Khalida, primary, De Macedo, Mariana Petaccia, primary, Austin-Breneman, Jacob L., primary, Jiang, Hong, primary, Chang, Qing, primary, Reddy, Sangeetha M., primary, Chen, Wei-Shen, primary, Tetzlaff, Michael T., primary, Broaddus, Russell J., primary, Davies, Michael A., primary, Gershenwald, Jeffrey E., primary, Haydu, Lauren, primary, Lazar, Alexander J., primary, Patel, Sapna P., primary, Hwu, Patrick, primary, Hwu, Wen-Jen, primary, Diab, Adi, primary, Glitza, Isabella C., primary, Woodman, Scott E., primary, Vence, Luis M., primary, Wistuba, Ignacio I., primary, Amaria, Rodabe N., primary, Kwong, Lawrence N., primary, Prieto, Victor, primary, Davis, R. Eric, primary, Ma, Wencai, primary, Overwijk, Willem W., primary, Sharpe, Arlene H., primary, Hu, Jianhua, primary, Futreal, P. Andrew, primary, Blando, Jorge, primary, Sharma, Padmanee, primary, Allison, James P., primary, Chin, Lynda, primary, and Wargo, Jennifer A., primary

Published
2023
Full Text
View/download PDF

29. Supplemental Data from Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade

Author

Ariyan, Charlotte E., primary, Brady, Mary Sue, primary, Siegelbaum, Robert H., primary, Hu, Jian, primary, Bello, Danielle M., primary, Rand, Jamie, primary, Fisher, Charles, primary, Lefkowitz, Robert A., primary, Panageas, Kathleen S., primary, Pulitzer, Melissa, primary, Vignali, Marissa, primary, Emerson, Ryan, primary, Tipton, Christopher, primary, Robins, Harlan, primary, Merghoub, Taha, primary, Yuan, Jianda, primary, Jungbluth, Achim, primary, Blando, Jorge, primary, Sharma, Padmanee, primary, Rudensky, Alexander Y., primary, Wolchok, Jedd D., primary, and Allison, James P., primary

Published
2023
Full Text
View/download PDF

30. Data from Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study

Author

Daver, Naval, primary, Garcia-Manero, Guillermo, primary, Basu, Sreyashi, primary, Boddu, Prajwal C., primary, Alfayez, Mansour, primary, Cortes, Jorge E., primary, Konopleva, Marina, primary, Ravandi-Kashani, Farhad, primary, Jabbour, Elias, primary, Kadia, Tapan, primary, Nogueras-Gonzalez, Graciela M., primary, Ning, Jing, primary, Pemmaraju, Naveen, primary, DiNardo, Courtney D., primary, Andreeff, Michael, primary, Pierce, Sherry A., primary, Gordon, Tauna, primary, Kornblau, Steven M., primary, Flores, Wilmer, primary, Alhamal, Zainab, primary, Bueso-Ramos, Carlos, primary, Jorgensen, Jeffrey L., primary, Patel, Keyur P., primary, Blando, Jorge, primary, Allison, James P., primary, Sharma, Padmanee, primary, and Kantarjian, Hagop, primary

Published
2023
Full Text
View/download PDF

31. Supplementary Figures 1 - 13 from Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

Author

Chen, Pei-Ling, primary, Roh, Whijae, primary, Reuben, Alexandre, primary, Cooper, Zachary A., primary, Spencer, Christine N., primary, Prieto, Peter A., primary, Miller, John P., primary, Bassett, Roland L., primary, Gopalakrishnan, Vancheswaran, primary, Wani, Khalida, primary, De Macedo, Mariana Petaccia, primary, Austin-Breneman, Jacob L., primary, Jiang, Hong, primary, Chang, Qing, primary, Reddy, Sangeetha M., primary, Chen, Wei-Shen, primary, Tetzlaff, Michael T., primary, Broaddus, Russell J., primary, Davies, Michael A., primary, Gershenwald, Jeffrey E., primary, Haydu, Lauren, primary, Lazar, Alexander J., primary, Patel, Sapna P., primary, Hwu, Patrick, primary, Hwu, Wen-Jen, primary, Diab, Adi, primary, Glitza, Isabella C., primary, Woodman, Scott E., primary, Vence, Luis M., primary, Wistuba, Ignacio I., primary, Amaria, Rodabe N., primary, Kwong, Lawrence N., primary, Prieto, Victor, primary, Davis, R. Eric, primary, Ma, Wencai, primary, Overwijk, Willem W., primary, Sharpe, Arlene H., primary, Hu, Jianhua, primary, Futreal, P. Andrew, primary, Blando, Jorge, primary, Sharma, Padmanee, primary, Allison, James P., primary, Chin, Lynda, primary, and Wargo, Jennifer A., primary

Published
2023
Full Text
View/download PDF

32. Data from Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade

Author

Ariyan, Charlotte E., primary, Brady, Mary Sue, primary, Siegelbaum, Robert H., primary, Hu, Jian, primary, Bello, Danielle M., primary, Rand, Jamie, primary, Fisher, Charles, primary, Lefkowitz, Robert A., primary, Panageas, Kathleen S., primary, Pulitzer, Melissa, primary, Vignali, Marissa, primary, Emerson, Ryan, primary, Tipton, Christopher, primary, Robins, Harlan, primary, Merghoub, Taha, primary, Yuan, Jianda, primary, Jungbluth, Achim, primary, Blando, Jorge, primary, Sharma, Padmanee, primary, Rudensky, Alexander Y., primary, Wolchok, Jedd D., primary, and Allison, James P., primary

Published
2023
Full Text
View/download PDF

34. Data from Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade

Author

Chen, Pei-Ling, primary, Roh, Whijae, primary, Reuben, Alexandre, primary, Cooper, Zachary A., primary, Spencer, Christine N., primary, Prieto, Peter A., primary, Miller, John P., primary, Bassett, Roland L., primary, Gopalakrishnan, Vancheswaran, primary, Wani, Khalida, primary, De Macedo, Mariana Petaccia, primary, Austin-Breneman, Jacob L., primary, Jiang, Hong, primary, Chang, Qing, primary, Reddy, Sangeetha M., primary, Chen, Wei-Shen, primary, Tetzlaff, Michael T., primary, Broaddus, Russell J., primary, Davies, Michael A., primary, Gershenwald, Jeffrey E., primary, Haydu, Lauren, primary, Lazar, Alexander J., primary, Patel, Sapna P., primary, Hwu, Patrick, primary, Hwu, Wen-Jen, primary, Diab, Adi, primary, Glitza, Isabella C., primary, Woodman, Scott E., primary, Vence, Luis M., primary, Wistuba, Ignacio I., primary, Amaria, Rodabe N., primary, Kwong, Lawrence N., primary, Prieto, Victor, primary, Davis, R. Eric, primary, Ma, Wencai, primary, Overwijk, Willem W., primary, Sharpe, Arlene H., primary, Hu, Jianhua, primary, Futreal, P. Andrew, primary, Blando, Jorge, primary, Sharma, Padmanee, primary, Allison, James P., primary, Chin, Lynda, primary, and Wargo, Jennifer A., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Methods from Caveolin-1 Upregulation Contributes to c-Myc–Induced High-Grade Prostatic Intraepithelial Neoplasia and Prostate Cancer

Author

Yang, Guang, primary, Goltsov, Alexei A., primary, Ren, Chengzhen, primary, Kurosaka, Shinji, primary, Edamura, Kohei, primary, Logothetis, Richard, primary, DeMayo, Francesco J., primary, Troncoso, Patricia, primary, Blando, Jorge, primary, DiGiovanni, John, primary, and Thompson, Timothy C., primary

Published
2023
Full Text
View/download PDF

44. Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study

Author

Morris, Van K, Salem, Mohamed E, Nimeiri, Halla, Iqbal, Syma, Singh, Preet, Ciombor, Kristen, Polite, Blase, Deming, Dustin, Chan, Emily, Wade, James L, Xiao, Lianchun, Bekaii-Saab, Tanios, Vence, Luis, Blando, Jorge, Mahvash, Armeen, Foo, Wai Chin, Ohaji, Chimela, Pasia, Manolo, Bland, Gail, Ohinata, Aki, Rogers, Jane, Mehdizadeh, Amir, Banks, Kimberly, Lanman, Richard, Wolff, Robert A, Streicher, Howard, Allison, James, Sharma, Padmanee, and Eng, Cathy

Published
2017
Full Text
View/download PDF

50. supplemental legend from Image Analysis–based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non–small Cell Lung Carcinoma Patients

Author

Parra, Edwin R., primary, Behrens, Carmen, primary, Rodriguez-Canales, Jaime, primary, Lin, Heather, primary, Mino, Barbara, primary, Blando, Jorge, primary, Zhang, Jianjun, primary, Gibbons, Don L., primary, Heymach, John V., primary, Sepesi, Boris, primary, Swisher, Stephen G., primary, Weissferdt, Annikka, primary, Kalhor, Neda, primary, Izzo, Julie, primary, Kadara, Humam, primary, Moran, Cesar, primary, Lee, Jack J., primary, and Wistuba, Ignacio I., primary

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results